| Theme | Testify the concepts of renal osteodystrophy and chronic kidney disease-bone and mineral disorder (CKD-MBD) | |
|---|---|---|
| Title | Clinical significance of outcomes and CKD-MBD practice markers | |
| Publish Date | 2015/06 | |
| Author | Keitaro Yokoyama | Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine |
| [ Summary ] | The term 'renal osteodystrophy' has recently been replaced by 'chronic kidney disease-mineral and bone disorder (CKD-MBD)', which includes abnormalities in bone and mineral metabolism, as well as vascular calcification. The Japanese Society for Dialysis Therapy's clinical practice guidelines for management of secondary hyperparathyroidism in chronic dialysis patients were originally published in Japanese in 2006. The guidelines were revised to include a number of new policies. A new guideline was published in Japanese in 2012. These guidelines were established to address outcomes concerned with mortality in CKD patients. This article outlines the clinical significance of outcomes and practice markers in relation to the CKD-MBD guidelines. | |